RxDoctor Payments Data

Adam Sassoon, MD

Adult Reconstructive Orthopaedic Surgery · Los Angeles, CANPI 1750580882

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Smith+Nephew at 53.5% of the total.

$274,499in general payments, 2019–2025

Across 348 payments — averaging $788.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$147K
  • Biocomposites Inc$73K
  • Orthalign Inc$37K
  • Zimmer Biomet$16K
  • Bone Support Inc.$1K
  • Overture Orthopaedics$247
  • plus $715 from 7 others
$23,943in research payments, 2019–2025

Across 2 payments — averaging $11,972 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$24K
$82,696in ownership & investment interests, 2019–2025

Across 1 payment — averaging $82,696 each. An ownership or investment interest held by the physician or an immediate family member.

  • Overture Orthopaedics$83K

What the payments were for

  • Consulting fees$146,01353%
  • Speaking & faculty fees$87,38432%
  • Travel & lodging$21,7968%
  • Food & beverage$19,2887%
  • Entertainment$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew160$146,871
Biocomposites Inc66$73,128
Orthalign Inc41$37,012
Zimmer Biomet68$15,526
Bone Support Inc.1$1,000
Overture Orthopaedics3$247
Johnson & Johnson2$227
My01 Inc.1$151
Stryker1$145
UOC USA Inc1$96
Globus Medical1$40
Dynasplint Systems Inc.2$35
Heron Therapeutics, Inc.1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$274,499 in reported general payments places this provider in the 85th percentile of 136 adult reconstructive orthopaedic surgery providers in California.

See all adult reconstructive orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$256,578
Medicare patients
398
Services billed
6,251

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib31$825
Tramadol Hcl25$126
Cephalexin58$96
Oxycodone Hcl15$91
Meloxicam34$85

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →